Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

1.3K
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.3K
Vaccines01:21

Vaccines

98
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the...
98
Vaccinations01:51

Vaccinations

44.1K
Overview
44.1K
Vaccine Production01:23

Vaccine Production

144
Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
144
Bacterial Gastroenteritis01:18

Bacterial Gastroenteritis

88
Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid...
88
Human Virome01:26

Human Virome

47
The human body harbors a vast and diverse viral community known as the human virome. The virome includes bacteriophages that infect bacteria, and eukaryotic viruses that infect human cells. Transient dietary and environmental viruses also contribute to this dynamic ecosystem. Estimates suggest the human body may contain on the order of 10¹³ viral particles, though abundance varies widely by body site and detection method.Comprehensive characterization of the virome has become possible...
47

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Temporal Connectivity of Social Contact Networks in Urban and Rural India.

Epidemiology (Cambridge, Mass.)·2026
Same author

Early-life gut microbiome composition and rotavirus vaccine-induced IgA responses in U.S. infants: a longitudinal cohort study.

EBioMedicine·2026
Same author

Number Needed to Vaccinate with a Novel Tuberculosis Vaccine to Prevent Tuberculosis in High-Risk Populations, United States.

medRxiv : the preprint server for health sciences·2026
Same author

Targeted Tuberculosis (TB) Vaccination Strategies in the United States: A Modeling Study.

medRxiv : the preprint server for health sciences·2026
Same author

A Novel Transmission Model-based Method to Evaluate Population Attribution Methods for Norovirus and Rotavirus Diarrhea.

Epidemiology (Cambridge, Mass.)·2026
Same author

Modeling the impact of adherence to U.S. isolation and masking guidance on SARS-CoV-2 transmission in office workplaces in 2021-2022.

medRxiv : the preprint server for health sciences·2026

Related Experiment Video

Updated: Apr 30, 2026

Assays for the Specific Growth Rate and Cell-binding Ability of Rotavirus
10:49

Assays for the Specific Growth Rate and Cell-binding Ability of Rotavirus

Published on: January 28, 2019

10.9K

Rotavirus vaccines: current status and future considerations.

Catherine Yen1, Jacqueline E Tate2, Terri B Hyde3

  • 1Division of Viral Diseases; Centers for Disease Control and Prevention; Atlanta, GA USA; Global Immunization Division; Centers for Disease Control and Prevention; Atlanta, GA USA.

Human Vaccines & Immunotherapeutics
|April 24, 2014
PubMed
Summary

Rotavirus vaccines significantly reduce severe diarrhea in children globally. Further research and policy support are crucial for wider adoption, especially in low-income countries, to maximize public health impact.

Keywords:
diarrheagastroenteritisrotavirusrotavirus vaccinesvaccine impact

More Related Videos

Simplified Reverse Genetics Method to Recover Recombinant Rotaviruses Expressing Reporter Proteins
11:40

Simplified Reverse Genetics Method to Recover Recombinant Rotaviruses Expressing Reporter Proteins

Published on: April 17, 2020

8.6K
An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay
09:14

An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay

Published on: January 26, 2019

10.6K

Related Experiment Videos

Last Updated: Apr 30, 2026

Assays for the Specific Growth Rate and Cell-binding Ability of Rotavirus
10:49

Assays for the Specific Growth Rate and Cell-binding Ability of Rotavirus

Published on: January 28, 2019

10.9K
Simplified Reverse Genetics Method to Recover Recombinant Rotaviruses Expressing Reporter Proteins
11:40

Simplified Reverse Genetics Method to Recover Recombinant Rotaviruses Expressing Reporter Proteins

Published on: April 17, 2020

8.6K
An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay
09:14

An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay

Published on: January 26, 2019

10.6K

Area of Science:

  • Public Health
  • Vaccinology
  • Pediatrics

Background:

  • Rotavirus is a primary cause of severe diarrhea in children under five worldwide.
  • Existing rotavirus vaccines demonstrate efficacy and effectiveness, leading to reduced disease burden in many nations.
  • Substantial public health gains remain unrealized as many countries, particularly those with high disease incidence, have not adopted rotavirus vaccines.

Purpose of the Study:

  • To review research informing rotavirus vaccine introduction decisions in diverse settings.
  • To identify strategies for enhancing oral rotavirus vaccine performance in developing countries.
  • To explore alternative immunization approaches and address policy barriers to vaccine uptake.

Main Methods:

  • Literature review of rotavirus vaccine effectiveness, impact, and safety studies.
  • Analysis of strategies to improve oral vaccine performance, including micronutrient supplementation.
  • Examination of policy and program-level barriers to vaccine introduction.

Main Results:

  • Effectiveness, impact, and safety data in low-income settings are essential for informed decisions.
  • Zinc supplementation and alternative parenteral immunization strategies show promise for improving vaccine performance.
  • Financial and programmatic challenges hinder vaccine adoption in high-burden countries.

Conclusions:

  • Further research is needed to establish rotavirus vaccine utility in resource-limited settings.
  • Optimizing oral vaccine delivery and exploring novel immunization methods are critical.
  • Addressing financial and policy barriers is paramount for global rotavirus vaccine implementation.